Literature DB >> 27545351

Echocardiographic Parameters During Long and Short Interdialytic Intervals in Hemodialysis Patients.

Konstantinos Tsilonis1, Pantelis A Sarafidis2, Vasilios Kamperidis1, Charalampos Loutradis3, Panagiotis I Georgianos4, Konstantinos Imprialos3, Antonios Ziakas1, Georgios Sianos1, Pavlos Nikolaidis4, Anastasios N Lasaridis4, Haralambos Karvounis1.   

Abstract

BACKGROUND: The long interdialytic interval in thrice-weekly hemodialysis is associated with excess cardiovascular risk. However, the mechanisms behind these adverse consequences are not fully understood. This study investigated the interdialytic changes in right and left ventricular function during the 2- and 3-day intervals. STUDY
DESIGN: Observational study with 2 random crossover sequences of recordings: 3-day followed by 2-day interval or vice versa. SETTINGS & PARTICIPANTS: 41 stable patients with end-stage renal disease on standard thrice-weekly hemodialysis therapy. PREDICTOR: 3-day (long) versus 2-day (short) interdialytic interval. OUTCOME: Interdialytic change in echocardiographic indexes of left and right ventricular function. MEASUREMENTS: 2-dimensional echocardiographic and tissue Doppler imaging studies were performed with a Vivid 7 cardiac ultrasound system at the start and end of the 3- and 2-day interdialytic intervals.
RESULTS: During both intervals studied, elevations in cardiac output, stroke volume, left ventricular mass index, and peak early diastolic velocities of the left ventricle were evident. Interdialytic weight gain (3.0±1.7 vs 2.4±1.3 [SD] kg) and inferior vena cava diameter increase (0.54±0.3 vs 0.25±0.3) were higher during the 3-day versus the 2-day interval (P<0.001). Left ventricular systolic and diastolic function indexes were generally no different between interdialytic intervals. In contrast, interdialytic increases in left and right atrial volume, right ventricular systolic pressure (RVSP; 15.3±10.2 vs 4.7±5.2mmHg; P<0.001), and tricuspid regurgitation maximum velocity (0.46±0.45 vs 0.14±0.33m/s; P=0.001) were significantly greater during the 3- versus the 2-day interval. Multivariable analysis suggested that changes in interdialytic weight gain, right ventricle diastolic function, and pulmonary vascular resistance were determinants of the change in RVSP. LIMITATIONS: Observational study design.
CONCLUSIONS: Excess volume accumulation over the long interdialytic interval in hemodialysis patients results in higher left and right atrial enlargement and RVSP elevation, which clinically corresponds to pulmonary circulation overload, providing one plausible pathway for the excess mortality risk during this period.
Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Long interdialytic interval; atrial enlargement; cardiovascular risk; echocardiography; end-stage renal disease (ESRD); hemodialysis; pulmonary circulation overload; right ventricular systolic pressure (RVSP); volume excess

Mesh:

Year:  2016        PMID: 27545351     DOI: 10.1053/j.ajkd.2016.06.017

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

Review 1.  The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD.

Authors:  Charalampos Loutradis; Pantelis A Sarafidis; Christodoulos E Papadopoulos; Aikaterini Papagianni; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2018-03-28       Impact factor: 10.121

2.  Predictors of Hyperkalemia among Patients on Maintenance Hemodialysis Transported to the Emergency Department by Ambulance.

Authors:  Amanda J Vinson; Wayel Zanjir; Megi Nallbani; Judah Goldstein; Janel Swain; David A Clark; Keigan M More; John R Manderville; Patrick T Fok; Hana Wiemer; Karthik K Tennankore
Journal:  Kidney360       Date:  2022-02-09

3.  Increased Right Ventricular Pressure as a Predictor of Acute Decompensated Heart Failure in End-Stage Renal Disease Patients on Maintenance Hemodialysis.

Authors:  Bong-Joon Kim; Soo-Jin Kim; Sung-Il Im; Hyun-Su Kim; Jung-Ho Heo; Ho Sik Shin; Ye Na Kim; Yeonsoon Jung; Hark Rim
Journal:  Int J Heart Fail       Date:  2022-04-15

4.  Association of Ambulatory Blood Pressure with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: Effects of Heart Failure and Atrial Fibrillation.

Authors:  Christopher C Mayer; Julia Matschkal; Pantelis A Sarafidis; Stefan Hagmair; Georg Lorenz; Susanne Angermann; Matthias C Braunisch; Marcus Baumann; Uwe Heemann; Siegfried Wassertheurer; Christoph Schmaderer
Journal:  J Am Soc Nephrol       Date:  2018-07-25       Impact factor: 10.121

5.  The impact of hemodialysis schedules on the day of the week of hospitalization for cardiovascular and infectious diseases, over a period of 20 years.

Authors:  Masataka Banshodani; Hideki Kawanishi; Shingo Fukuma; Misaki Moriishi; Sadanori Shintaku; Shinichiro Tsuchiya
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

6.  Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Jennifer E Flythe; Tara I Chang; Martin P Gallagher; Elizabeth Lindley; Magdalena Madero; Pantelis A Sarafidis; Mark L Unruh; Angela Yee-Moon Wang; Daniel E Weiner; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Kevan R Polkinghorne
Journal:  Kidney Int       Date:  2020-03-08       Impact factor: 10.612

7.  The association between longer haemodialysis treatment times and hospitalization and mortality after the two-day break in individuals receiving three times a week haemodialysis.

Authors:  James Fotheringham; Ayesha Sajjad; Vianda S Stel; Keith McCullough; Angelo Karaboyas; Martin Wilkie; Brian Bieber; Bruce M Robinson; Ziad A Massy; Kitty J Jager
Journal:  Nephrol Dial Transplant       Date:  2019-09-01       Impact factor: 5.992

Review 8.  Volume overload in hemodialysis: diagnosis, cardiovascular consequences, and management.

Authors:  Charalampos Loutradis; Pantelis A Sarafidis; Charles J Ferro; Carmine Zoccali
Journal:  Nephrol Dial Transplant       Date:  2021-12-02       Impact factor: 5.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.